Trial Profile
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Indium 111 DTPA adenosylcobalamin (Primary)
- Indications Brain cancer; Lung cancer
- Focus Diagnostic use
- Sponsors Copharos
- 03 Jun 2014 New trial record